51532-0242-2 : NDC 2026 Code

51532-0242-2 : Acetaminophen, Aspirin, Caffeine, Salicylamide ( Pain Free )

Additionally :

You can get information about “51532-0242-2” NDC code in 51532-0242-2 in HTML format

HTML | 51532-0242-2 in TXT (Plain Text) format

TXT | 51532-0242-2 in PDF (Portable Document Format)

PDF | 51532-0242-2 in XML format

XML formats.

NDC Code : 51532-0242-2 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51532-0242-2",
    "PackageDescription": "2 TABLET in 1 PACKET (51532-0242-2)",
    "NDC11Code": "51532-0242-02",
    "ProductNDC": "51532-0242",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Pain Free",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Aspirin, Caffeine, Salicylamide",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20161025",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH NOT FINAL",
    "ApplicationNumber": "part343",
    "LabelerName": "Afassco Inc.",
    "SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE",
    "StrengthNumber": "110; 162; 32.4; 152",
    "StrengthUnit": "1/1; 1/1; 1/1; 1/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2023-01-03",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20221231",
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}